An Accurate Genetic Model for Predicting the Carrier Status of mmr-gene Mutations Fabio Marroni 1, Piero Benatti 2, Mariapina Montera 3, Daniela Barana.

Slides:



Advertisements
Similar presentations
A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates Peter Calabrese & Darryl Shibata Question: A fundamental.
Advertisements

Applications of HGP Genetic testing Forensics. Testing for a pathogenic mutation in a certain gene in an individual that indicate a persons risk of developing.
Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
International Society for Gastrointestinal Hereditary Tumours (InSiGHT): Edited highlights Düsseldorf, 2009.
Universal Screening of Lynch Syndrome Heather Hampel, MS, CGC Clinical Associate Professor, Division of Human Genetics.
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Evaluating Diagnostic Accuracy of Prostate Cancer Using Bayesian Analysis Part of an Undergraduate Research course Chantal D. Larose.
Risk Assessment for HNPCC
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Sponsored by Division of Cancer Control and Population Sciences Division of Cancer Epidemiology and Genetics Office of Women’s Health National Cancer Institute,
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
© 2001 Myriad Genetic Laboratories Northern Nevada Genetic Counseling Robbin Palmer Certified Genetic Counselor
About these slides SPEC – Short Presentation in Emerging Concepts
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Estimating the penetrances of breast and ovarian cancer in the carriers of BRCA1/2 mutations Silvano Presciuttini University of Pisa, Italy.
Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.
Genetic Susceptibility Risk Models in Clinical Decision Making Susan M. Domchek, MD Abramson Cancer Center University of Pennsylvania.
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
1 PRACTICAL ASPECTS OF ASSESSING MSI STATUS: WHAT TESTS TO ORDER AND HOW TO INTERPRET THEM by HENRY T. LYNCH, M.D. JANE F. LYNCH, B.S.N. CARRIE SNYDER,
ESTIMATING CANCER PENETRANCES FROM GENETIC TEST RESULTS: Analysis of the Families from the Italian Registry of Hereditary Breast/ovarian Cancer Fabio Marroni,
HNPCC and MLH1 Qi Peng Cancer Biology March 30 th, 2006.
Determining Phenotypes of Pathogenic Mismatch Repair Mutants Brett Palama Lab of Andrew Buermeyer, Ph.D. Dept. of Environmental/Molecular Toxicology.
PERFORMANCE OF DIFFERENT MODELS PREDICTING THE PRE-TEST PROBABILITY OF CARRYING MUTATIONS IN BRCA1 OR BRCA2 IN 330 ITALIAN FAMILIES Silvano Presciuttini,
IGES 2003 How many markers are necessary to infer correct familial relationships in follow-up studies? Silvano Presciuttini 1,3, Chiara Toni 2, Fabio Marroni.
Development of a genetic model predicting the carrier status for mmr-gene mutations Fabio Marroni 1, Piero Benatti 2, Mariapina Montera 3, Daniela Barana.
Microsatellite Instability Detection by Next Generation Sequencing S.J. Salipante, S.M. Scroggins, H.L. Hampel, E.H. Turner, and C.C. Pritchard September.
GENOME-WIDE LINKAGE SCAN IN A LARGE FAMILY WITH SUSPECTED GENETIC PREDISPOSITION TO CANCER Marroni F. 1, Lipkin S. 2, Benatti P. 3, Pedroni M. 3, Bailey-Wilson.
West Midlands Regional Genetics Laboratory
Immunohistochemistry (IHC) for Microsatellite Instability Fact Sheet Frequently Asked Questions What is Lynch Syndrome? Lynch syndrome is a hereditary.
Blueprint of Life Topic 9: Pedigrees
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
1Day 2 Section 7 Introduction to survival analysis.
Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.
Familial Risk and Surveillance of Colon and Rectum Malcolm Dunlop Academic Coloproctology & Colon Cancer Genetics Group University of Edinburgh & Western.
What are Microsatellites? D2S123 TAGGCCACACACACACACACA Unique Primer Mono, di, tri, tetra nucleotide repeats HNPCC - Expansion/contraction of nl repeats.
Bonny Blackard Biology 169 April 4, 2006
A GENETIC MODEL FOR PREDICTING THE CARRIER STATUS OF MSH2/MLH1 MUTATIONS: RESULTS OF AN ITALIAN MULTICENTER STUDY F. Marroni 1,2, P. Benatti 3, A. Viel.
1 LYNCH SYNDROME EPCAM FAMILY WITH PREDOMINANT COLORECTAL CANCER HENRY T. LYNCH, MD; STEPHEN N. THIBODEAU, PHD; CARRIE SNYDER, MSN, RN, APNG; JENNIFER.
Isella et al., Supplemenrary Figure 1. ROC curve analysis for MACC1, MET and HGF gene dosage, as indicated.
Variant Classification and Reclassification. Introduction This slide presentation covers several topics pertaining to Variant classification, reclassification.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic.
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer In association.
Date of download: 5/31/2016 From: The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications[dhelix] Ann Intern Med. 2003;138(7):
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Hereditary Colorectal Cancer:
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
West Midlands Regional Genetics Laboratory
Susan Domchek, MD University of Pennsylvania
A Retrospective Analysis of Microsatellite Instability testing on colorectal cancer specimens in Queensland Public Hospitals Matthew Burge; Hayden Christie;
What are Microsatellites?
Hereditary Gastrointestinal Cancers
New Approaches to Cancer Susceptibility Testing
Hereditary Colorectal Cancer: From Genetic Testing to Prevention
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Lynch syndrome (LS) Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder
Representative 3-generation pedigrees for serous cancer probands suggestive of inherited cancer susceptibility. Representative 3-generation pedigrees for.
Volume 151, Issue 5, Pages e3 (November 2016)
Noralane M Lindor  Clinical Gastroenterology and Hepatology 
DiagMMR™ assay validation sample collection
Inherited DNA-Repair Defects in Colorectal Cancer
Association of Hereditary Nonpolyposis Colorectal Cancer–Related Tumors Displaying Low Microsatellite Instability with MSH6 Germline Mutations  Ying Wu,
Colorectal cancer at a young age
Giovanni Parmigiani, Donald A. Berry, Omar Aguilar 
Inherited DNA-Repair Defects in Colorectal Cancer
Covering the Cover Gastroenterology
A, Proportion of variants detected in the MMR genes.
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Frequently mutated genes in colorectal cancer.
Presentation transcript:

An Accurate Genetic Model for Predicting the Carrier Status of mmr-gene Mutations Fabio Marroni 1, Piero Benatti 2, Mariapina Montera 3, Daniela Barana 4, Monica Pedroni 2, Margherita Torrini 3, Luca Roncucci 2, Cristina Oliani 4, Cristina Mareni 3, Maurizio Ponz de Leon 2, Generoso Bevilacqua 1 and Silvano Presciuttini 1 1 Università di Pisa 2 Università di Modena 3 Università di Genova 4 Ospedale Maggiore - Verona

Introduction A relevant proportion of HNPCC families is attributable to germline mutations in MLH1 and MSH2 Lifetime risk of developing a CRC is more than 70% in mutation carriers. Female carriers also have a 30% lifetime risk of developing endometrial cancer Early detection of mmr-gene mutations can substantially reduce the lifetime risk of developing cancer Accurate evaluation of the probability that an individual carries a germline pathogenic mutation at MLH1 or MSH2 is therefore essential to help counselors and counselands decide whether testing is appropriate.

Aim of the study To refine a genetic model developed previously, evaluating the probability of carrying a germline mutation in MSH2 or MLH1 To use information on MSI for the calculation of carrier probability To compare the performance of this predictive model with that of Wijnen (Wijnen et al, NEJM, 1998) on our dataset, including 105 families screened for mmr-genes, in which 28 mutations were identified

Model Parameter Values Colorectal and endometrial cancer penetrances in carriers of mmr-genes mutations were obtained from published data (Vasen et al, JCO, 2001) Penetrances in the general population were obtained by national cancer registries Frequency of mmr-genes mutations was set to (Dunlop et al, BJC, 2000)

Genetic model Penetrances

Microsatellite Instability (MSI) Knowledge of microsatellite status (stability or instability) can help predicting carrier status. MSI is an indicator of increased mutation risk. The increase in risk was measured in our data as the increased fraction of mutations detected in MSI probands. MSS tumors are rarely observed in carriers of mmr- gene mutations: we therefore set the posterior probability of being carrier given MS stable phenotype to 1/10 th of the prior probability.

MSI and mutations in families stratified by risk

Mutation probabilities corrected by MS status The interpolated quadratic curve is used to correct prior probabilities

Results In our dataset of 105 families, 28 mutations were observed. The use of microsatellite data increased performance of both models. (Chi-square value in bracket)

Results Area under ROC curves significantly increased in both models after the inclusion of microsatellite data.

Conclusions The genetic model performed better than Wijnen model in term of observed/expected ratio, while the AUC was similar. Both models show an important increase in performance when taking into account data on MSI.